A new study links telomere length and polygenic risk scores to IPF development, highlighting genetic drivers beyond rare variants.
David Zhang, MD
Advertisement
David Zhang, MD, is a pulmonary disease medicine specialist at Columbia University Irving Medical Center.
Articles by David Zhang, MD
A new study links telomere length genetics to IPF risk, showing how rare variants and polygenic scores may guide future screening and precision care.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
Home-Based Heart Failure Care Shows Comparable Safety to Continued Inpatient Care
3
Cardiology Prices Vary Widely by Insurer and State
4
Voice Biomarkers Show Promise for Asthma, COPD Exacerbation Detection
5